Iatrogenic Thyrotoxicosis. Causal Circumstances, Pathophysiology and Principles of Treatment. Review of the Literature

Acta Chirurgica Belgica

Volumn , Issue 6, 2001, Pages 257-266

  Meurisse, M ^a,b   Preudhomme, L ^a   Lamberty, G ^a   Meurisse, N ^a   Bataille, Y ^a   Defechereux, Th ^a   Hamoir, E ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b CHU SART TILMAN   (Belgium)

Author keywords

Iatrogenic; Thyroid crisis; Thyroid diseases; Thyrotoxicosis

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; IODINE;

EPIDEMIOLOGY; HUMAN; PATHOPHYSIOLOGY; PATIENT SELECTION; PHYSIOLOGY; REVIEW; THYROTOXICOSIS;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; CAUSALITY; HUMANS; IODINE; PATIENT SELECTION; THYROTOXICOSIS;

EID: 0035522555     PISSN: 00015458     EISSN: 25770160     Source Type: Journal    
DOI: None     Document Type: Review

References (120)

1. BARCLAY M. L., BROWNLIE B. E. W., TURNER J. G., WELLS J. E. Lithium associated thyrotoxicosis : a report of 14 cases, with statistical analysis of incidence. Clin Endocrinol, 1994, 40 : 759-764, 1994.
2. MCDERMOTT M. T., BURMAN K. D., HOFELDT F. D., KIDD J. S. Lithium-associated thyrotoxicosis. Am J Med, 1986, 80 : 1245-48.
3. YASSA, R., SANDERS, A., NASTASE, C., CAMILLE, Y.: Lithium-induced thyroid disorders : a prevalence study. J Clin Psych, 1988, 49 : 14-16.
4. BERENS S. C., BERNSTEIN R. S., ROBBINS J., WOLFF J. Antithyroid effects of lithium. J Clin Invest, 1970, 47 : 1357-1367.
5. BROWNLIE E. W., CHAMBERS S. T., SADLER W. A., DONALD R. A. Lithium-associated thyroid disease, areport of 14 cases of hypothyroidism and 4 cases of thyrotoxicosis. Aust NZ J Med, 1976, 6 : 223-229.
6. EMERSON C. H., DYSON W. L., UTIGER R. D. Serum thyrotropin and thyroxin concentrations in patients receiving lithium carbonate. J Clin Endocrinol Med, 1973, 289 : 136-138.
7. WILSON R., MCKILLOP J. H., CROCKET G. T., PEARSON C., JENKINS C., BURNS F., BURNETT A. K., THOPSON J. A. The effects of lithium therapy on parameters thought to be involved in the development of autoimmune thyroid disease. Clin Endocrinol, 1991, 34 : 357-361.
8. WEETMAN R., MCGREGOR A. M., LAZARUS J. H., REES SMITH B., HALL R. The enhancement of immunoglobulin synthesis by human lymphocytes with lithium. Clin Imm Immunopath, 1982, 22 : 400-401.
9. MIZUKAMI Y., MICHIGISHI T., NONOMURA A. Histological features of the thyroid gland in a patient with lithium induced thyrotoxicosis. J Clin Pathol, 1995, 48 : 582-587.
10. RABIN P. L., EVANS D. C. Exophtalmos and elevated thyroxine levels in association with lithium therapy. J Clin Psychiatry, 1981, 42 : 398-400.
11. FRANKLIN L. M. Thyrotoxicosis developing during lithium treatment : case report. NZ Med J, 1974, 79 : 782.
12. TODD J., JERRAM T. C. Thyrotoxicosis during lithium treatment. Br J Clin Prac, 1978, 32 : 201-203.
13. THOMPSON C. J., BAYLIS P. H. Asymptomatic Graves' disease during lithium therapy. Postgrad Med J, 1986, 62 : 295-296.
14. TURNER J. G., BROWNLIE B. E. W., ROGERS T. G. H. Lithium as an adjunct to radioiodine therapy for thyrotoxicosis. Lancet, 1976, i : 614-615.
15. VIALETTES B., GUILLERAND M. A., VIENS P., STOPPA A. M., BAUME D., SAUVAN R., PASQUIER J., SAN MARCO M., OLIVE D., MARANINCHI D. Incidence rate and risks factors for thyroid dysfunction during recombinant interleukin-2 therapy in advanced malignancies. Acta Endocrinol, 1993, 129 : 31-38.
16. ATKINS M., MIER J., DEMCHAK P., ROBERT N., PARKINSON D., KAPLAN M. Thyroid dysfunction following IL-2 therapy. Proc Am Soc Clin Oncol, 1990, 9 : 186.
17. SCHWARTENTRUBER D. J., WHITE DE ZWEIG M. H., WEINTRAUB B. D., ROSENBERG S. A. Thyroid dysfunction associated with immunotherapy for patients with cancer. Cancer, 1991, 68 : 2384-2390.
18. PICHERT G., JOST L. M., ZÖBELI L., ODERMATT B., PEDIO G., STAHEL R. A. Thyroiditis after treatment with interleukin-2 and interferon α-2a. Br J Cancer, 1990, 62 : 100-104.
19. KASUGA Y., MATSUBAYASHI S., AKASU F., MILLER N., JAMIESON C., VOLPE R. Effects of recombinant human interleukin-2 and tumor necrosis factor-α with or without interferon-γ on human thyroid tissues from patients with Graves' disease and from normal subjects xenografted into nude mice. J Clin Endocrinol Metab, 1991, 72 : 1296-1301.
20. PREZIATI D., LA ROSA L., COVINI G. Autoimmunity and thyroid function in patients with chronic active hepatitis treated by recombinant interferon alpha-2a. Eur J Endocrinol, 1995, 132 : 587-593.
21. ROTI E., MINELLI R., GIUBERTI T., MARCHELLI S., SCHIANCHI C., GARDINI E., SALVI M., FIACCADORI F., UGOLOTTI G., NERI T. M., BRAVERMAN L. E. Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon alpha. Am J Med, 1996, 101 : 482-487.
22. GUERIN V., TODD I., HAMMONDI L. J., BOTTAZZO G. F. Suppression of HLA class II expression on thyrocytes by interferonalpha. Clin Exp Immunol, 1990, 79 : 341-345.
23. YAMAZAKI K., KANAJI Y., SHIZUMZ K. Reversible inhibition by interferon alpha and beta of 1251 incorporation and thyroid hormone release by human thyroid follicules in vitro. J Clin Endocrinol Metab, 1993, 77 : 1439-1441.
24. JACOBS E. L., CLARE-SALZLER M. J., CHOPRA I. J., FIGLIN R. A. Thyroid function abnormalities associated with the chronic out-patient administration of recombinant interleukin-2 and recombinant interferon-alpha. J Immunother, 1991, 10 : 448-455.
25. WEETMAN A. P., MCGREGOR A. M. Autoimmune thyroid disease : further developments in our understanding. Endocr Rev, 1994, 15 : 788-830.
26. KOH L. K. H., GREESPAN F. S., YEO P. P. B. Interferon alpha induced thyroid dysfunction : three clinical presentations and review of the literature. Thyroid, 1997, 7 : 891-896.
27. LECKIE R. G., BUCKNER A. B., BORNEMANN M. Seat belt-related thyroiditis documented with thyroid Tc-99m pertechnetate scans. Clin Nucl Med, 1992, 17 : 859-860.
28. BLUM M., SCHLOSS M. F. Martial arts thyroiditis (letter to the editor). N Engl J Med, 1984, 311 : 199.
29. CALL R. A., COHEN K. L. Transient thyroiditis due to surgical trauma. Am J Med, 1993, 95 : 546-548.
30. KOBAYACHI A., KUMA K., MATSUZUKA F., HIRAI K., FUKATA S., SUGAWARA M. Thyrotoxicosis after needle aspiration of thyroid cyst. J Clin Endocrinol Metab, 1992, 75 : 21-24.
31. WALFISCH P., CAPLAN D., ROSEN I. B. Postparathyroidectomy transient thyrotoxicosis. J Clin Endocrinol Metab, 1992, 75 : 224-227.
32. CARNEY J. A., MOORE S. B., NORTHCUTT R. C., WOOLNER L. B., STILLWELL G. K. Palpation thyroiditis (multifocal granulomatous folliculitis). Am J Clin Pathol, 1975, 64 : 639-647.
33. KAY T. W. H., D'EMDEN M. C., ANDREWS J. T., MARTIN F. I. R. Treatment of non toxic multinodular goiter with radioactive iodine. AM J Med, 1988, 84 : 19-22.
34. HUYSMANS D. A. K. C., HERMUS R. M. M., EDELBROECK M. A. L., TJABBES T., OOSTDIJK A., ROSS A., CORSTENS F. H. M., KLOPPENBORG P. W. C. Autoimmune hyperthyroidism occuring late after radioiodine treatment for volume reduction of large multinodular goiters. Thyroid, 1997, 7 : 535-539.
35. 131 I therapy. Thyroid, 1999, 9 : 477-481.
36. 131 I treatment in patients with non toxic goiter. J Clin Endocrinol Metab, 1997, 82 : 2926-2930.
37. STUDER H., PETER H. J., GERBER H. Natural heterogeneity of thyroid cells : the basis for understanding thyroid function and nodular growth. Endocr Rev, 1989, 10 : 125-129.
38. TONACCHERA M., CHIOVATO R., PINCHERA A., AGRETTI P., FIORE E., CETANI F., ROCCHI R., VIANCAVA P., MICCOLI P., VITTI P. Hyperfunctioning thyroid nodules in toxic multinodular goiter share activating thyrotropin receptor mutations with solitary adenoma. J Clin Endocrinol Metab, 1998, 83 : 492-498.
39. MCGREGOR A. M., MCLACHAN S. M., SMITH B. R., HALL R. Effect of irradiation on the thyroid-autoantibody production. Lancet, 1979, ii : 442-444.
40. WEETMAN A. P. Autoimmune thyroiditis : predisposition and pathogenesis. Clin Endocrinol, 1992, 36 : 307-323.
41. KAY T., HEYMA P., HARRISSON L., MARTIN F. I. R. Graves' disease induced by radioactive iodine. Ann Intern Med, 1987, 107 : 857-858.
42. FACHNJE J. D., RAO S. D. Painless thyroiditis with hyperthyroidism following external irradiation of the neck. Henry Ford Hosp Med J, 1980, 28 : 149-151.
43. MORTIMER R. H., HILL G. E., GALLIGAN J. P., BRANDSEN A. I., TYACK S. A., ROESER H. P. Hypothyroidism and Grves' disease after mantle irradiation : a follow-up study. Aust NZ J Med, 1986, 16 : 347-351.
44. WASNICH R. D., GRUMET F. C., PAYNE R. O., KRISS J. P. Ophtalmopathy following external neck irradaition for non thyroidal neoplastic disease. J Clin Endocrinol Metab, 1973, 37 : 304-308.
45. MCGREGOR A. M., MCLACHLAN S. M., REES SMITH B., HALL R. Effect of irradiation on thyroid autoantibody production. Lancet, 1979, ii : 442-445.
46. ROSE E., SANDERS T. P., WEEB JR W. L., HINES R. C. Occult factitial thyrotoxicosis. Ann Intrenn Med, 1969, 71 : 309-313.
47. GREER M. A. Thyrotoxicosis of extrathyroid origin. In : Ingbar S. H., Braverman L. E. (eds. ), Werner's The Thyroid, ed 5. J. B. Lippincott Co, Philadelphia, p. 1120, 1986.
48. ROGERS H. M. The cardiovascular manifestations of induced thyrotoxicosis ; report of two cases. Ann Intern Med, 1947, 26 : 914-918.
49. COHEN J. H., INGBAR S. H., BRAVERMAN L. E. Thyrotoxicos due to ingestion of excess thyroid hormone. Endocr Rev, 1989, 10 : 113-124.
50. SIEGENBEEK VAN HEULEKOM L. H., DER KINDEREN P. J., VINGERHEODS A. C. M. Plasmapheresis in L-thyroxine intoxication. Plasma Therapy, 1980, 1 : 33-38.
51. OHNO F., MIYOSHI K. Clinical observations on thyreoidismus medicamentosus due to weight reducing pills in Japan. Endocrinol Jpn, 1971, 18 : 321-325.
52. HEDBERG C. W., FISHBEIN D. B., JANSSEN R. S., MEYERS B., MACMILLEN J. M., MACDONALD K. L., WHITE K. E., HUSS L. J., HURWITZ E. S., FARHIE J. R., SIMMONS J. L., BRAVERMAN L. E., INGBAR S. H., SCHONBERGER L. B., OSTERHOLM M. T. An outbreak of thyrotoxicosis caused by the consumption of bovine thyroid gland in ground beef. N Engl J Med, 1897, 316 : 993-998.
53. KINNEY J. S., HURWITZ E. S., FISHBEIN D. B., WOOLF P. D., PINSKY P. F., LAWRENCE D. N., ANDERSON L. J., HOLMES J. P., WILSON C. K., LOSCHEN D. J., NORDLUND H. M., OLDFATHER J., RODEY G. E., STOESZ P. A., SCHOENBERGER L. B. Community outbreak of thyrotoxicosis : epidemiology, immunogenetic characteristics, and long-term outcome. Am J Med, 1987, 84 : 10-18.
54. STANGE W. F., HENSKE J. A. Accidental ingestion of poisons. J Pediatr, 1955, 47 : 470-479.
55. RIGGS D. S., MAN E. B., WINKLER A. W. Serum iodine of euthyroid subject treated with dessicated thyroid. J Clin Invest, 1945, 24 : 722-726.
56. BHASIN S., WALLACE W., LAWRENCE J. B., LESCH M. Sudden death associated with thyroid hormone abuse. Am J Med, 1981, 71 : 887-889.
57. VELTRI J. C., LITOVITZ T. L. 1983 annual report of the american association of poison control centers national data collection system. Am J Emer Med, 1983, 2 : 420-431.
58. GORMAN R. L., CHAMBERLAIN J. M., ROSE S. R. Massive levothyroxine overdose : high anxiety- low toxicity. Pediatrics, 1988, 82 : 666-670.
59. MAY M. E., MINTZ P. D., LOWRY P., GELLER R., CURNOW R. T. Plasmapheresis in thyroxine overdose : a case report. J Toxicol Clin Toxicol, 1984, 20 : 517-519.
60. VON HOFE S., YOUNG R. L. Thyrotoxicosis after a single ingestion of levothyroxine. JAMA, 1977, 237 : 1361-1362.
61. GERARD P., MALVAUX P., DE VISSCHER M. Accidental poisoning with thyroid extract treated by exchange transfusion. Arch Dis Child, 1972, 47 : 980-982.
62. NYSTRÖM E., LINDSTEDT G., LUNDBERG P. A. Minor signs and symptoms of toxicity in a young woman in spite of massive thyroxine ingestion. Acta Med Scand, 1980, 207 : 135-137.
63. DAHLBERG P. A., KARLSSON F. A., WIDE L. TRIIODOTHYROXINE INTOXICATION. LANCET, 1979, II : 700-702.
64. MARIOTTI S., MARTINO E., CUPINI C., LARI R., GIANI C., BASCHIERI L., PINCHERA A. Low serum thyroglobulin as a clue to the diagnosis of thyrotoxicosis factitia. N Engl J Med, 1982, 307 : 410-415.
65. CHOPRA I. J., SOLOMON D. H., CHOPRA U., WU S. Y., FISHER D. A., NAKAMURA Y. Pathways of metabolism of thyroid hormones. Recent Prog Horm Res, 1978, 34 : 521-567.
66. CHOPRA I. J., VAN HERLE A. J., KORENMAN S. G., VIOSCA S., YOUNAI S. Use of sodium ipodate in management of hyperthyroidism in subacute thyroiditis. J Clin Endocr Metab, 1995, 80 : 2178-2180.
67. BERKNER P. D., STARKMAN H., PERSON N. Acute L-thyroxine overdose ; therapy with sodium ipodate : evaluation of clinical and physiologic parameters. J Emerg Med, 1991, 9 : 129-131.
68. GREEN W. L. Effect of drugs on thyroid function. In : WY S. Y. (ed.). Thyroid hormone metabolism. Boston : Blackwell ; 239-265, 1991.
69. DEGROOT L. J., RUE P. A. Roentgenographic contrats agents inhibit triiodothyronine binding to nuclear receptors in vitro. J Clin Endocrinol Metab, 49 : 538-542, 1979.
70. WOLFF J., CHAIKOFF I. L. Plasma inorganic iodide as homeostatic regulator of thyroid function. J Biol Chem, 1949, 174 : 555-568.
71. WOLFF J., CHAIKOFF I. L., GOLDBERG R. C. The temporary nature of the inhibitory action of excess iodide on organic iodine synthesis in the normal thyroid. Endocrinology, 1949, 45 : 504-510.
72. FRADKIN J. E., WOLFF J. Iodide-induced thyrotoxicosis. Medicine. 1983, 62 : 1-20.
73. MARTINS L. M., LIMA N., KNOBEL M. Natural course of iodine-induced thyrotoxicosis (Jodbasedow) in endemic goiter area. A 5-year follow-up. J Endocrinol Invest, 1989, 12 329-336.
74. LONDON W. T., VOUGHT R. L., BROWN F. A. Bread-a dietary source of large quantities of iodine. N Engl J Med, 1965, 273 : 381-383.
75. LAVELLE K. J., DOLDENS D. J., PLERT S. A. Iodine absorption in burn patients treated topically with povidone-iodine. Clin Pharmacol Ther, 1975, 17 : 355-357.
76. Ross D. S. Syndromes of thyrotoxicosis with low radioactive iodine uptake. Endocrinol Metab N Amer, 1998, 27 : 169-185.
77. LEGER F. A., BEAULIEU J., MALINSKY M., CHOMETTE G., SAVOIE J. Therapeutic aspects of iodine-induced thyrotoxicosis. Ann Endocrinol, 1977, 38 : 86A.
78. HARJAI K. J., LICATA A. A. Effects of Amiodarone on thyroid function. (Review). Ann Intern Med, 1997, 126 : 63-73.
79. REIFFEL J. A., ESTES N. A., WALDO A. L., PRYSTOWSKY E. N., DIBIANCO R. A consensus report on antiarrhythmic drug use. (Review) Clin Cardiol, 1994, 17 : 103-106.
80. CEREMUZYNSKI L., KLECZAR E., KRZEMINSKA-PAKULA M., KUCH J., NARTOWICZ E., SMIELAK-KOROMBEL J., DYDUSZYNSKI A., MACIEJEWICZ J., ZALESKA T., LAZARCZYK-KEDZIA E., MOTYKA J., PACZKOWSKA B., SCZANIECKA O., YUSUF S. Effects of amiodarone on mortality after myocardial infarction : a double-blind, placebo-controlled, pilot study. J Am Coll Cardiol, 1992, 20 : 1056-1062.
81. CHATTERJEE K. Amiodarone in chronic heart failure. (Editorial). J Am Coll Cardiol, 1989, 14 : 1775-1776.
82. ALBERT S. G., ALVES L. E., ROSE E. P. Thyroid dysfunction during chronic amiodarone therapy. J Am Coll Cardiol, 1987, 9 : 175-183.
83. NADEMANEE K., PIWONKA R. W., SINGH B. N., HERSHMAN J. M. Amiodarone and thyroid function. (Review). Prog Cardiovasc Dis, 31 : 427-437, 1989.
84. CHARLIER R., DELTOUR G., BAUDINE A., CHAILLET F. Pharmacology of amiodarone, an anti-anginal drug with a new biological profile. Arzneimittelforschung, 1968, 18 : 1408-1417.
85. ROTI E., VAGENAKIS A. G. : Effect of excess iodide : clinical aspects. In : Braveman L. E., Utiger R. D. (eds.). Werner and Ingbar's The Thyroid. A fundamental and clinical text. Philadelphia, J. B. Lippincott Company, 1991, pp. 390-402.
86. RAO R. H., MCCREADY V. R., SPATHIS G. S. Iodine kinetic studies during amiodarone treatment. J Clin Endocrinol Metab. 1986, 62 : 563-568.
87. FIGGE H. L., FIGGE J. The effects of amiodarone on thyroid hormone function : a review of the physiology and clinical manifestations. J Clin Pharmacol, 1990, 30 : 588-595.
88. BROEKHUYSEN J., LARUEL R, SION R. Recherches dans la série des benzofuranes XXXVII. Etude comparée du transit et du métabolisme de l'amiodarone chez diverses espèces animales et chez l'homme. Arch Int Pharmacodyn Ther, 1969, 177 : 340-359.
89. SINGH B. N. Amiodarone : historical development and pharmacology profiles. (Review). Am Heart J, 1983, 106 : 788-797.
90. LOMBARDI A., MARTINO E., BRAVERMAN L. E. Amiodarone and the thyroid. Thyroid Today, 1990, 13 : 1-7.
91. MARTINO E., AGHINI-LOMBARDI F., MACCHIA E. Amiodarone-induced thyrotoxicosis. Italian Journal of medecine, 1986, 2 : 15-20.
92. MEHRA A., WIDERHORN J., LOPRESTI J., RAHIMTOOLA S. H. Amiodarone-induced hyperthyroidism : thyroidectomy under local anesthesia. Am Heart J, 1991, 122 : 1160-1161.
93. MARTINO E., AGHINI-LOMBARDI F., MARIOTTI S., BARTALENA L., BRAVERMAN L. E., PINCHERA A. Amiodarone : a common source of iodine-induced thyrotoxicosis. Horm Res, 1987, 26 : 158-171.
94. MEURISSE M., HAMOIR E., D'SILVA M., JORIS J., HENNEN G. Amiodarone-induced thyrotoxicosis : is there a place for surgery ? World J Surg, 1993, 17 : 622-627.
95. GEORGES J. L., NORMAND J. P., LENORMAND M., SCHWOB J. Life-threatening thyrotoxicosis induced by amiodarone in patients with benign heart disease. Ear Heart J, 1992, 13 : 129-132.
96. HAUPTMAN P. J., FYFE B., MECHANICK J., LANSMAN S., GASS A. Fatal hyperthyroidism after amiodarone treatment and total lymphoid irradiation in a heart transplant recipient. J Heart Lung Transplant, 1993, 12 : 513-516.
97. LEGER A. F., MASSIN J. P., LAURENT M. F., VINCENS M., AURIOL M., HELAL O. B., CHOMETTE G., SAVOIE J. C. Iodine-induced thyrotoxicosis : analysis of eighty-five consecutive cases. Eur J Clin Invest, 1984, 14 : 449-455.
98. PECHE R., ABRAMOWICZ M., UNGER J. Failure to respond to dexamethasone with fatal consequences, after initial response to multidrug treatment in a case of amiodarone-associated thyrotoxicosis. (Review). Am J Med, 1992, 93 : 702-703.
99. BROUSSOLLE C., DUCOTTET X., MARTIN C., BARBIER Y., BORNET H., NOEL G., ORGIAZZI J. Rapid effectiveness of prednisone and thionamides combined therapy in severe amiodarone iodine-induced thyrotoxicosis. Comparison of two groups of patients with apparently normal glands. J Endocrinol Invest, 1989, 12 : 37-42.
100. HENNEN G., MARY-RABINE L., MEURISSE M. Hyperthyroidies sévères induites par l'iode : une urgence chirurgicale. Rev Med Liège, 1992, 47 : 237-244.
101. SOGOL P. B., HERSHMAN J. M., REED A. W., DILLMAN W. H. The effects of amiodarone on serum thyroid hormones and hepatic thyroxine 5′-monodeiodination in rats. Endocrinology, 1983, 113 : 1464-1469.
102. BARTALENA L., BROGIONI S., GRASSO L., BOGAZZI F., BURELLI A., MARTINO E. J. Clin. Treatment of amiodarone induced thyrotoxicosis, a difficult challenge : results of a prospective study. Endocrinol Metab, 1996, 81 : 2930-2933.
103. SMYRK T. C., GOELLNER J. R., BRENNAN M. D., CARNEY J. A. Pathology of the thyroid gland in amiodarone-associated thyrotoxicosis. Am J Surg Pathol, 1987, 11 : 197-202.
104. BARTALENA L., GRASSO L., BROGIONI S., BOGAZZI F., BURELLI A., MARTINO E. Serum interleukin-6 in amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab, 1994, 78 : 423-427.
105. BOGAZZI F., BARTALENA L., BROGIONI S., MAZZEO S., VITTI P., BURELLI A., BARTOLOZZI C., MARTINO E. Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis. Thyroid, 1997, 7 : 541-545.
106. HAMOIR E., MEURISSE M., DEFECHEREUX T., JORIS J., VIVARIO J., HENNEN G. Surgical management of amiodarone-associated thyrotoxicosis : too risky or too effective ? World J Surg. 1998, 22 : 537-543.
107. NEWMAN C. M., PRICE A., DAVIES D. W., GRAY T. A., WEETMAN A. P. Amiodarone and the thyroid : a practical guide to the management of thyroid dysfunction induced by amiodarone therapy. Heart, 1998, 79 : 121-127.
108. BRENNAN M. D., VAN HEERDEN J. A., CARNEY J. A. Amiodarone-associated thyrotoxicosis (AAT) : experience with surgical management. Surgery, 1987, 102 : 1062-1069.
109. FARWELL A. P., ABEND S. L., HUANG S. K., PATWARDHAN N. A., BRAVERMAN L. E. Thyroidectomy for amiodarone-induced thyrotoxicosis. JAMA, 1990, 263 : 1526-1528.
110. DONAGHUE K. C., CLARKE P., HOOPER M. J. Amiodarone. The dilemma of hyperthyroxinaemia and the treatment of thyrotoxicosis. Med J Aust, 1985, 142 : 594-596.
111. BRONSTEIN V., COIGNARD A., GAUTHIER D., DURET J. C., DRONIOU J. Thyrotoxicose sevère et surcharge iodée. A propos d'un cas d'évolution mortelle. Presse Med, 1992, 11 : 2226.
112. ROSENBAUM M. B., CHIALE P. A., HAEDO A., LAZZARI J. O., ELIZARI M. V. Ten years of experience with amiodarone. Am Heart J, 1983, 106 : 957-964.
113. REICHERT L. J., DE ROOY H. A. Treatment of amiodarone induced hyperthyroidism with potassium perchlorate and methimazole during amiodarone treatment. Br Med J. 1989, 298 : 1547-1548.
114. BOEHM T. M., MCLAIN J., BURMAN K. D., DE SHAZO R., WARTOFSKY L. Iodine treatment of iodine induced thyrotoxicosis. J Endocrinol Invest, 1980, 3 : 419-424.
115. KASAI K., SUZUKI H., SHIMODA S. I. Effects of propylthiouracile and relatively small doses od iodine on early phase treatment of hyperhtyroidism ? Acta Endocrinol (Copenh.), 1980, 93 : 315-321.
116. JOHNSON R. S., MOORE W. G. Fatal aplastic anemia after treatment of thyrotoxicosis with potassium perchlorate. Br Med J, 1961, 1 : 1369-1371.
117. UZZAN B., PUSSARD E., LEON A., BEKHECHI D., KRIVITZKY A., MODIGLIANI E., PERRET G., VASSY R., BERDEAUX A., GUIDICELLI J. F. The effects of plasmapheresis on thyroid hormone and plasma drug concentrations in amiodarone-induced thyrotoxicosis. Br J Clin Pharmacol, 1991, 31 : 371-372.
118. SAMARAS K., MAREL G. M. Failure of plasmapheresis, corticosteroids and thionamides to ameliorate a case of proctated amiodarone-induced thyroiditis. Clin Endocrinol, 1996, 45 : 365-368.
119. MULLIGAN D. C., MCHENRY C. R., KINNEY W., ESSELSTEYN C. B. Amiodarone-induced thyrotoxocosis : clinical presentation and expanded indications for thyroidectomy. Surgery, 1993, 114 : 1114-1119.
120. KOBLIN D. D., ROMANOFF M. E., MARTIN D. E., HENSEEY F. A., LARACH D. R., STAUFFER R. A., LUCK J. Anaesthetic management of the paturient receiving amiodarone. Anesthesiology, 1987, 66 : 551-553.